The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure
Abstract
:1. Introduction
2. Results
2.1. General Characteristics
2.2. Hepatic HIF-1α Expression in CLD and ACLF
2.3. Hepatic HIF-1α Expression in Human Liver Samples
2.4. Extrahepatic HIF-1α Expression
3. Discussion
4. Materials and Methods
4.1. Animals
4.2. Induction of Chronic Liver Disease
4.3. Induction of Acute-on-Chronic Liver Failure
4.4. Additional Animal Models
4.5. Human Liver Tissue
4.6. Animal Tissue and Blood Collection
4.7. Histology
4.8. Hepatic Hydroxyproline Content
4.9. Quantitative Polymerase Chain Reaction
4.10. Western Blotting
4.11. Transcriptome Analysis
4.12. Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Moreau, R.; Jalan, R.; Gines, P.; Pavesi, M.; Angeli, P.; Cordoba, J.; Durand, F.; Gustot, T.; Saliba, F.; Domenicali, M.; et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013, 144, 1426–1437.e9. [Google Scholar] [CrossRef]
- Arroyo, V.; Moreau, R. Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis. J. Hepatol. 2017, 66, 451–453. [Google Scholar] [CrossRef] [PubMed]
- Bernal, W.; Jalan, R.; Quaglia, A.; Simpson, K.; Wendon, J.; Burroughs, A. Acute-on-chronic liver failure. Lancet 2015, 386, 1576–1587. [Google Scholar] [CrossRef]
- Trebicka, J.; Fernandez, J.; Papp, M.; Caraceni, P.; Laleman, W.; Gambino, C.; Giovo, I.; Uschner, F.E.; Jansen, C.; Jimenez, C.; et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J. Hepatol. 2021, 74, 1097–1108. [Google Scholar] [CrossRef] [PubMed]
- Engelmann, C.; Herber, A.; Franke, A.; Bruns, T.; Reuken, P.; Schiefke, I.; Zipprich, A.; Zeuzem, S.; Goeser, T.; Canbay, A.; et al. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study). J. Hepatol. 2021, 75, 1346–1354. [Google Scholar] [CrossRef] [PubMed]
- Hwang, S.; Hicks, A.; Hoo, C.Z.; Kwon, Y.S.; Cho, Y.E.; Moore, J.; Gao, B. Novel treatment of acute and acute-on-chronic liver failure: Interleukin-22. Liver Int. 2023. [Google Scholar] [CrossRef] [PubMed]
- Luo, J.; Li, J.; Li, P.; Liang, X.; Hassan, H.M.; Moreau, R.; Li, J. Acute-on-chronic liver failure: Far to go—A review. Crit. Care 2023, 27, 259. [Google Scholar] [CrossRef] [PubMed]
- Nath, B.; Szabo, G. Hypoxia and hypoxia inducible factors: Diverse roles in liver diseases. Hepatology 2012, 55, 622–633. [Google Scholar] [CrossRef] [PubMed]
- Kaelin, W.G., Jr.; Ratcliffe, P.J. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30, 393–402. [Google Scholar] [CrossRef] [PubMed]
- Semenza, G.L. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 2011, 365, 537–547. [Google Scholar] [CrossRef]
- Hirota, S.A.; Fines, K.; Ng, J.; Traboulsi, D.; Lee, J.; Ihara, E.; Li, Y.; Willmore, W.G.; Chung, D.; Scully, M.M.; et al. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology 2010, 139, 259–269.e3. [Google Scholar] [CrossRef]
- Peyssonnaux, C.; Cejudo-Martin, P.; Doedens, A.; Zinkernagel, A.S.; Johnson, R.S.; Nizet, V. Cutting edge: Essential role of hypoxia inducible factor-1 alpha in development of lipopolysaccharide-induced sepsis. J. Immunol. 2007, 178, 7516–7519. [Google Scholar] [CrossRef]
- HIF Signaling Pathway, Map 04066, KEGG PATHWAY Database. Available online: https://www.kegg.jp/entry/map04066 (accessed on 27 December 2023).
- Wicks, E.E.; Semenza, G.L. Hypoxia-inducible factors: Cancer progression and clinical translation. J. Clin. Investig. 2022, 132, e159839. [Google Scholar] [CrossRef] [PubMed]
- Wu, Q.; You, L.; Nepovimova, E.; Heger, Z.; Wu, W.; Kuca, K.; Adam, V. Hypoxia-inducible factors: Master regulators of hypoxic tumor immune escape. J. Hematol. Oncol. 2022, 15, 77. [Google Scholar] [CrossRef] [PubMed]
- Yuen, V.W.; Wong, C.C. Hypoxia-inducible factors and innate immunity in liver cancer. J. Clin. Investig. 2020, 130, 5052–5062. [Google Scholar] [CrossRef] [PubMed]
- Foglia, B.; Novo, E.; Protopapa, F.; Maggiora, M.; Bocca, C.; Cannito, S.; Parola, M. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells 2021, 10, 1764. [Google Scholar] [CrossRef] [PubMed]
- Moon, J.O.; Welch, T.P.; Gonzalez, F.J.; Copple, B.L. Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G582–G592. [Google Scholar] [CrossRef] [PubMed]
- Rosmorduc, O.; Housset, C. Hypoxia: A link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin. Liver Dis. 2010, 30, 258–270. [Google Scholar] [CrossRef] [PubMed]
- Wilson, G.K.; Tennant, D.A.; McKeating, J.A. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions. J. Hepatol. 2014, 61, 1397–1406. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.S.; Semela, D.; Iredale, J.; Shah, V.H. Sinusoidal remodeling and angiogenesis: A new function for the liver-specific pericyte? Hepatology 2007, 45, 817–825. [Google Scholar] [CrossRef]
- Arroyo, V.; Angeli, P.; Moreau, R.; Jalan, R.; Claria, J.; Trebicka, J.; Fernandez, J.; Gustot, T.; Caraceni, P.; Bernardi, M.; et al. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J. Hepatol. 2021, 74, 670–685. [Google Scholar] [CrossRef]
- Nishiyama, Y.; Goda, N.; Kanai, M.; Niwa, D.; Osanai, K.; Yamamoto, Y.; Senoo-Matsuda, N.; Johnson, R.S.; Miura, S.; Kabe, Y.; et al. HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J. Hepatol. 2012, 56, 441–447. [Google Scholar] [CrossRef] [PubMed]
- Shao, T.; Zhao, C.; Li, F.; Gu, Z.; Liu, L.; Zhang, L.; Wang, Y.; He, L.; Liu, Y.; Liu, Q.; et al. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J. Hepatol. 2018, 69, 886–895. [Google Scholar] [CrossRef] [PubMed]
- Chertow, G.M.; Pergola, P.E.; Farag, Y.M.K.; Agarwal, R.; Arnold, S.; Bako, G.; Block, G.A.; Burke, S.; Castillo, F.P.; Jardine, A.G.; et al. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N. Engl. J. Med. 2021, 384, 1589–1600. [Google Scholar] [CrossRef]
- Eckardt, K.U.; Agarwal, R.; Aswad, A.; Awad, A.; Block, G.A.; Bacci, M.R.; Farag, Y.M.K.; Fishbane, S.; Hubert, H.; Jardine, A.; et al. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. N. Engl. J. Med. 2021, 384, 1601–1612. [Google Scholar] [CrossRef]
- Markham, A. Vadadustat: First Approval. Drugs 2020, 80, 1365–1371. [Google Scholar] [CrossRef] [PubMed]
- Zhao, L.; Song, Y.; Zhang, Y.; Liu, H.; Shen, Y.; Fan, Y.; Li, Y.; Xie, K. HIF-1α/BNIP3L induced cognitive deficits in a mouse model of sepsis-associated encephalopathy. Front. Immunol. 2022, 13, 1095427. [Google Scholar] [CrossRef]
- Zaccherini, G.; Aguilar, F.; Caraceni, P.; Claria, J.; Lozano, J.J.; Fenaille, F.; Castelli, F.; Junot, C.; Curto, A.; Formentin, C.; et al. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. J. Hepatol. 2021, 74, 1117–1131. [Google Scholar] [CrossRef]
- Xie, F.; Dong, J.; Zhu, Y.; Wang, K.; Liu, X.; Chen, D.; Meng, Q. HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure. Ann. Hepatol. 2019, 18, 757–764. [Google Scholar] [CrossRef]
- Bihari, C.; Patil, A.; Shasthry, S.M.; Baweja, S.; Kumar, G.; Sarin, S.K. Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients. Hepatol. Int. 2020, 14, 597–608. [Google Scholar] [CrossRef]
- Klein, S.; Schierwagen, R.; Uschner, F.E.; Trebicka, J. Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension. Methods Mol. Biol. 2017, 1627, 91–116. [Google Scholar] [CrossRef]
- Holdener, M.; Hintermann, E.; Bayer, M.; Rhode, A.; Rodrigo, E.; Hintereder, G.; Johnson, E.F.; Gonzalez, F.J.; Pfeilschifter, J.; Manns, M.P.; et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J. Exp. Med. 2008, 205, 1409–1422. [Google Scholar] [CrossRef]
- Brol, M.J.; Rosch, F.; Schierwagen, R.; Magdaleno, F.; Uschner, F.E.; Manekeller, S.; Queck, A.; Schwarzkopf, K.; Odenthal, M.; Drebber, U.; et al. Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2019, 317, G182–G194. [Google Scholar] [CrossRef]
- Schwarzkopf, K.M.; Eberle, L.; Uschner, F.E.; Klein, S.; Schierwagen, R.; Mucke, M.M.; Schaefer, L.; Claria, J.; Zeuzem, S.; Hintermann, E.; et al. Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling? J. Hepatol. 2020, 73, 980–982. [Google Scholar] [CrossRef]
- Brook, B.; Amenyogbe, N.; Ben-Othman, R.; Cai, B.; Harbeson, D.; Francis, F.; Liu, A.C.; Varankovich, N.; Wynn, J.; Kollmann, T.R. A Controlled Mouse Model for Neonatal Polymicrobial Sepsis. J. Vis. Exp. JoVE 2019, 143, e58574. [Google Scholar] [CrossRef]
- Bertola, A.; Mathews, S.; Ki, S.H.; Wang, H.; Gao, B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 2013, 8, 627–637. [Google Scholar] [CrossRef] [PubMed]
- Trebicka, J.; Hennenberg, M.; Odenthal, M.; Shir, K.; Klein, S.; Granzow, M.; Vogt, A.; Dienes, H.P.; Lammert, F.; Reichen, J.; et al. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J. Hepatol. 2010, 53, 702–712. [Google Scholar] [CrossRef] [PubMed]
- Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
- Kohno, T.; Kubo, Y.; Yasui, K.; Haraguchi, M.; Shigematsu, S.; Chua, K.J.; Matsuyama, T.; Hayashi, H. Serum starvation activates NF-κB through G protein beta2 subunit-mediated signal. DNA Cell Biol. 2012, 31, 1636–1644. [Google Scholar] [CrossRef] [PubMed]
Gene | Assay ID | Species |
---|---|---|
HIF1A | Rn01472831_m1 | rat |
HIF1AN | Rn01766292_m1 | rat |
ELGN1 | Rn00710295_m1 | rat |
STAT3 | Rn00680715_m1 | rat |
NFκB1 | Rn01399572_m1 | rat |
PLCG2 | Rn01431998_m1 | rat |
PIK3CD | Rn01516709_m1 | rat |
NOS2 | Rn00561646_m1 | rat |
EPO | Rn01481376_m1 | rat |
18sRNA | REF: 4308329 | rat |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mücke, M.M.; El Bali, N.; Schwarzkopf, K.M.; Uschner, F.E.; Kraus, N.; Eberle, L.; Mücke, V.T.; Bein, J.; Beyer, S.; Wild, P.J.; et al. The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure. Int. J. Mol. Sci. 2024, 25, 1542. https://doi.org/10.3390/ijms25031542
Mücke MM, El Bali N, Schwarzkopf KM, Uschner FE, Kraus N, Eberle L, Mücke VT, Bein J, Beyer S, Wild PJ, et al. The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure. International Journal of Molecular Sciences. 2024; 25(3):1542. https://doi.org/10.3390/ijms25031542
Chicago/Turabian StyleMücke, Marcus M., Nihad El Bali, Katharina M. Schwarzkopf, Frank Erhard Uschner, Nico Kraus, Larissa Eberle, Victoria Therese Mücke, Julia Bein, Sandra Beyer, Peter J. Wild, and et al. 2024. "The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure" International Journal of Molecular Sciences 25, no. 3: 1542. https://doi.org/10.3390/ijms25031542